ArticleNature2026
A preinvasive regulatory T cell axis for lung cancer interception.
Abstract read
In one paragraph
Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
48 authors.
Samuel Gamble *Pre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.
Zoe E Whiteman *Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Claudia Peinador-Marín *Pre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0009-0003-9791-1176
Marta Lebrusant-Fernandez *Pre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.
Abigail Y L Shurr *Pre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0009-0002-6069-5871
Andrei Enica *Pre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0001-8117-2207
Teerapon Sahwangarrom *Pre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.
Seng Kuong Anakin Ung *Pre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.
Amber Rogers *Pre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0002-7071-7889
Petros Fessas *Pre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.
Chuen Ryan KhawLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Lukas KalinkeLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Constantin Ahlmann-EltzePre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.
Ahmed S N AlhendiLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID http://orcid.org/0000-0002-1883-2142
Kate OtterLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Xiuchuan HuLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Krupa ThakkarTumour Immunogenomics and Immunosurveillance Group, Research Department of Oncology, UCL Cancer Institute, University College London, London, UK.
Betty GrationPre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.
Izzy NewshamPre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0003-0816-4045
Imran UddinCRUK City of London Centre Single Cell Genomics Facility, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0003-0736-3149
Ellen Nuttall MussonPayne Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0002-0395-3304
Kyren A LazarusLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Moritz J PrzybillaSomatic Genomics Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-5645-9492
Adam PennycuickLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Helen HallLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Zoe HagelLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Charlotte PercivalLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Ruth PrendeckiLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Sophie TisiLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Georgia ConstantinouCell Signalling Laboratory, Research Department of Oncology, UCL Cancer Institute, University College London, London, UK.
Pascal F DurrenbergerLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Pre-Cancer Atlas Team
Kate H C GowersLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Yien Ning Sophia WongPre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.
Mark LinchUrological Cancer Biology Group, Research Department of Oncology, UCL Cancer Institute, University College London, London, UK.
Kevin LitchfieldCancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0002-3725-0914
Elspeth M PaynePayne Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0001-5841-778X
Se-Hoon LeeSamsung Medical Centre, Sungkyunkwan University, Seoul, South Korea.ORCID http://orcid.org/0000-0002-9219-3350
Sergio A QuezadaCancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0002-9763-1700
Peter J CampbellWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge, UK.ORCID http://orcid.org/0000-0002-3921-0510
Jennifer E BeaneHuman Tumor Atlas Network, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-6699-2132
Sarah A MazzilliHuman Tumor Atlas Network, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
David A MooreCancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0002-6296-1312
Vitor H TeixeiraLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID http://orcid.org/0000-0003-0090-861X
Sandra Gómez-LópezLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID http://orcid.org/0000-0001-5163-6066
Bart VanhaesebroeckCell Signalling Laboratory, Research Department of Oncology, UCL Cancer Institute, University College London, London, UK.ORCID http://orcid.org/0000-0002-7074-3673
Sam M JanesLungs for Living Research Centre, UCL Respiratory, University College London, London, UK. s.janes@ucl.ac.uk.ORCID http://orcid.org/0000-0002-6634-5939
James L ReadingPre-Cancer Immunology Laboratory, Research Department of Haematology, UCL Cancer Institute, University College London, London, UK. j.reading@ucl.ac.uk.ORCID http://orcid.org/0000-0001-5381-978X
Funding
No grant is acknowledged in the PubMed record.
Abstract
Late-stage non-small cell lung cancer (NSCLC) is rarely curable
Identifiers
PMID
42844481What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.